Clinical-stage oncology therapeutics company Whitehawk Therapeutics Inc (Nasdaq:WHWK) announced on Thursday that its president and CEO, Dave Lennon, PhD, will present at the Jefferies 2026 Global Healthcare Conference in New York City, NY on Thursday, 4 June at 8:10 AM ET.

A live webcast of the fireside chat can be accessed by visiting the Whitehawk Therapeutics IR website, and will be available for replay for approximately 30 days following the event.

Whitehawk Therapeutics applies advanced technologies to established tumour biology to deliver improved cancer treatments. Its advanced three-asset antibody drug conjugate (ADC) portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. These assets are in-licensed from WuXi Biologics under an exclusive development and global commercialisation agreement.